Effect of a Recombinant Human Soluble Thrombomodulin on Baseline Coagulation Biomarker Levels and Mortality Outcome in Patients With Sepsis-Associated Coagulopathy

OBJECTIVES: To assess the effects of recombinant human soluble thrombomodulin treatment on 28-day all-cause mortality in subgroups categorized by baseline coagulation biomarker levels (prothrombin fragment 1.2, thrombin-antithrombin complex, d-dimer) in patients with sepsis-associated coagulopathy i...

Descripción completa

Detalles Bibliográficos
Autores principales: Levi, Marcel, Vincent, Jean-Louis, Tanaka, Kosuke, Radford, Amanda H., Kayanoki, Toshihiko, Fineberg, David A., Hoppensteadt, Debra, Fareed, Jawed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365672/
https://www.ncbi.nlm.nih.gov/pubmed/32697484
http://dx.doi.org/10.1097/CCM.0000000000004426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365672/
https://www.ncbi.nlm.nih.gov/pubmed/32697484
http://dx.doi.org/10.1097/CCM.0000000000004426

Ejemplares similares